Quantification of sulfated polysaccharides in urine samples is relevant to pharmacokinetic studies in drug development projects and to the non-invasive diagnosis and therapy monitoring of mucopolysaccharidoses. The Heparin Red Kit is a particularly simple and user friendly fluorescence assay for the quantification of sulfated polysaccharides and has recently emerged as a novel tool for the monitoring of their blood levels during pharmacokinetic studies in clinical trials. The standard protocol for the blood plasma matrix is, however, not suited for urine samples due to matrix interference. The present study identifies inorganic sulfate as the interfering component in urine. The sulfate level of urine is typically 1-2 orders of magnitude higher compared with the blood plasma level. Addition of either hydrochloric acid or magnesium chloride counteracts sulfate interference but still enables sensitive detection of sulfated polysaccharides such as heparin, heparan sulfate and dermatan sulfate at low microgramm per milliliter levels. This study extends the application range of the Heparin Red Kit by a simple modification of the assay protocol to the direct quantification of various sulfated polysaccharides in human urine.
Introduction
Sulfated polysaccharides are complex biomacromolecules with a wide variety of biological activities. They comprise both approved drugs, such as the widely used anticoagulant heparin, and various drug candidates in preclinical or clinical development. Due to their inherent structural heterogeneity, quantification of sulfated polysaccharides in biological matrices is a challenging task. In the clinical setting, heparin blood levels are quantified by the antithrombin-mediated effect on coagulation or on specific coagulation factors. Such assays can not be readily transferred to other biological matrices. Heparin quantification in urine, for instance, is achieved by time consuming and challenging protocols that involve either radiolabeling [1, 2] or the isolation of heparin followed by colorimetry, possibly including electrophoresis [3, 4] . Depending on the analytical method, recovery of injected heparin doses in urine between 1 and 39 weight % were desribed. One study [4] has identified in urine in approximately 1:1 ratio both unchanged heparin and a partially desulfated metabolite in which the average sulfation per monosaccharide is reduced from 1.29 to 0.99. Recently there has been a renewed interest in heparin formulations for oral delivery [5, 6] , and quantification of excreted heparin in urine is part of the pharmacokinetic analysis. [7] Urinary levels between 0,2 and 4 µg/mL have been reported after oral uptake of a 1000 U heparin / kg body weight dose. [7] Urine levels of endogeneous sulfated polysaccharides (glycosaminoglycans, respectively) are elevated in several types of mucopolysaccharidoses, a group of genetic disorders caused by deficiency of enzymes needed to degrade the polysaccharides. Depending on MPS type, urinary levels of heparan sulfate and dermatan sulfate, for instance, can be ten to hundreds of times higher than the normal range. [8, 9] Dye-based methods (Berry spot test and dimethylmethylene blue photometry [10] ) that determine total urinnary glycosaminoglycans are routinely applied to the initial diagnostic screening for MPS. Quantification of specific polysaccharides in urine supports identification of the MPS type and therapy monitoring but requires more sophisticated analytical methodology such as HPLC-MS. [8, 9] Heparin Red is a new analytical tool for the direct detection of sulfated polysaccharides in complex biological matrices by a simple mix-and-read assay. It is a polycationic fluorescent dye (scheme 1) that forms non-fluorescent aggregates with the polyanionic target (scheme 2). [11, 12] Two assays based on Heparin Red have become commercially available [13] and been applied to the quantification of a variety of sulfated polysaccharides and biological matrices.[14-21] The Heparin Red Kit is of particular use for detections in a blood plasma matrix and has emerged as a new tool for pharmacokinetic studies of non-anticoagulant heparins that are difficult to quantify by other methods. [14, 22, 23] The standard protocol of this assay for plasma samples is, however, not suited for urine due to significant matrix interference. Another assay Heparin Red Ultra was reported to detect heparin in urine but is not sensitive to polysaccharides with a lower sulfation degree. [21] Scheme 1. Major repeating disaccharide units of the sulfated polysaccharide heparin (left).
Structure of the polycationic fluorescent probe Heparin Red (right). In this contribution, we identify the interference of the Heparin Red Kit in urine samples as inorganic sulfate and describe simple modifications of the assay protocol to overcome this interference. The adapted protocol enables not only the detection of heparin but also of less sulfated polysaccharides such as dermatan sulfate and heparan sulfate in urine.
Materials and Methods

Instrumentation
Fluorescence measurements
Fluorescence was measured with a microplate reader Biotek Synergy Mx (Biotek Instruments, Winooski, VT, USA), excitation at 570 nm, emission recorded at 605 nm, spectral band width 17 nm, gain 100, read height of 8 mm. Black 96 well microplates for fluorescence, polystyrene, Item No 655076, were purchased from Greiner Bio-One GmbH, Frickenhausen.
pH measurements
The pH value in DMSO-water 4:1 mixtures was measured with a glass electrode (InLab ® Micro, SemiMicro, Mettler Toledo) that was freshly calibrated using aqueous buffers pH 4.0 and pH 7.0.
Reagents
Heparin Red® Kit
The Heparin Red Kit was a gift from Redprobes UG, Münster, Germany.
Sulfated polysaccharides
Unfractionated heparin sodium salt from porcine intestine mucosa was purchased from Sigma-Aldrich GmbH, Steinheim, product number H5515, Lot SLBK0235V. Heparan sulfate from porcine mucosa, highly purified fractions I and III (Cat No GAG-HS I and GAG-HS III)
were purchased from Iduron Ltd, Cheshire, UK. Dermatan sulfate sodium from porcine mucosa, product number C3788 (referred to as chondroitin sulfate B), batch SLBM9912V, was purchased from Sigma-Aldrich (Taufkirchen, Germany). According to the certificate of analysis of the provider, the batch contains 9% water, 6.5% S and 8.6% Na.
Urine
Urine 1 is a commercially available pooled normal human urine Katalog Nr: IR100007P-1000, Lot 17317, from Innovative Research. Urine 2 is a pool urine from three healthy donors. Urines were stored at -20°C and thawed before use. Spiked urine samples were either used directly after spiking, or stored at -20°C and thawed prior to use.
Other
Aqueous solutions were prepared with HPLC grade water purchased from VWR, product No 23595.328. Inorganic salts were >99% pure. 18-crown-6 was purchased from Sigma Aldrich, product number 186651, Lot 0000041795. Hydrochloric acid (1.0 M), product number 35328, Lot # SZBF2050V, was purchased from Sigma-Aldrich (Taufkirchen, Germany).
Assays
Heparin Red® Kit, standard protocol
The protocol of the provider for a 96-well microplate assay with plasma samples was 
Barium sulfate precipitation
The urine sample was mixed with 9 vol% of a 100 mM BaCl 2 solution and kept in a 1.5 mL Eppendorf tube at ambient temperature for 10 minutes. The mixture was then centrifuged at 10000 rpm for 5 minutes.
Sulfate assay
Sulfate concentrations in urine were determined by the commercial Sulfate Test 101812 (Merck KGaA, Darmstadt), based on photometric turbidity measurement after precipitation as BaSO 4 . Instructions of the provider were followed. A 100-fold dilution of the urine sample was applied.
Results and discussion
Sulfate interferes with the Heparin Red assay
A preliminary screening of the abundant inorganic ions in urine ( assay solution comparable to that described for figure 1. This is confirmed by measuring pH 6.0, identical to that of the assay solution of figure 1 at 2 mM sulfate. Sulfate in the urine 1 sample was quantified by a commercial assay that detected 4.7 mM, a concentration at the lower limit of the reference range for urine (table 1) . Strong fluorescence quenching at this sulfate concentration is in line with the data in figure 1 . The urine level of sulfate (table 1) is 1-2 orders of magnitude higher than the plasma or serum level which is normally in the range 0.25 to 0.4 mM [35] [36] [37] . This readily explains why sulfate interference is not relevant to plasma samples since this concentration does not trigger fluorescence quenching of Heparin Red ( figure 1, figure 3 ). additive has no effect on fluorescence response to the urine sample (data not shown). The pH of the HCl containing assay solution after mixing with the urine sample was 3.1, and in line with the results outlined in figure 2 an interference by urinary sulfate is not expected under these conditions due to its conversion to non-interfering HSO 4 -.
The sensitivity of the assay for a specific sulfated polysaccharide depends on the sulfation degree of the latter (table 2) . The higher the sulfation, the less polysaccharide is needed to form a charge neutral complex with Heparin Red [12] , and the more sensitive the assay is.
Considering pKa 8 for acetic acid in the DMSO water 80:20 assay solution [25, 34] , we assume protonation of the carboxylate groups of the analytes (scheme 1). Therefore, only the sulfate groups remain for electrostatic binding to polycationic Heparin Red (scheme 1, 2). 8 ).
We have therefore evaluated another protocol modification, the addition of 50 mM MgCl 2 to the reagent solution [20] , for detection of sulfated polysaccharides in urine samples. The presence of endogeneous sulfated polysaccharides in urine should be considered as a potential cause of background signal in the Heparin Red assay. According to a recent LCMS analysis [42] , the overall sulfated polysaccharide concentration in human urine averages to about 4.8 µg/mL and is a mixture of 83 % chondroitin sulfates (CS, including dermatan sulfate) and 17 % heparan sulfate. Individual levels are, however, highly variable and can range from <1 µg/mL to 10 µg/mL. Average sulfation per monosaccharide is 0.32 for urinary CS and 0.35 for urinary HS (derived from the data in [42] ). This corresponds to a lower sulfation compared with any sulfated polysaccaride investigated in the present study (table   2) , and endogeneous urinary CS and HS might be relatively poor targets for the Heparin Red assay. Fluorescence of the unspiked pool urine samples in figure 6 is comparable to that of a HS and DS are urinary biomarkers for most types of mucopolysaccharidoses (MPS). In MPS type I-III, 100-200 times higher than normal urinary HS levels were determined by HPLC analysis.
[8] A 6-10fold elevation of DS was reported for children with MPS type I and VI. [9] The modified Heparin Red assay as described in Figure 5 
